{"product_id":"novel-and-re-emerging-respiratory-viral-diseases-isbn-9780470065389","title":"Novel and Re-emerging Respiratory Viral Diseases","description":"The past decade has seen mounting global concern regarding viral outbreaks such as SARS, avian influenza and West Nile virus. In 2004 and 2005, reports of bird-to-human, and possible human-to-human, transmissions of the H5N1 influenza viruses raised fears that these viruses could cause a pandemic on the scale of the Spanish flu pandemic of 1918.   Previous to this, a novel coronavirus had been identified as the aetiological agent of the severe acute respiratory syndrome (SARS), a new respiratory viral disease that emerged at the end of 2002 and caused profound disturbances in over 30 countries worldwide in 2003. It is not known whether the SARS coronavirus will re-emerge, especially since its origins and potential reservoir(s) are unresolved. However, these outbreaks have shown that these viruses can emerge in any part of the world at any time.  \u003cp\u003eThis book critically evaluates the latest scientific evidence on novel or re-emerging viral diseases and brings together contributions from world experts on this topic, explaining best practice in their area, and discussing lessons learned and how best to collaborate to prevent and control future outbreaks.\u003c\/p\u003e \u003cp\u003e\u003cbr\u003e Topics covered include:\u003c\/p\u003e \u003cul\u003e \u003cli\u003ethe latest advances in virology, particularly in the area of epidemiology\u003c\/li\u003e \u003cli\u003ediagnostics\u003c\/li\u003e \u003cli\u003eanimal models for viral infection\u003c\/li\u003e \u003cli\u003eantiviral and vaccine development\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003ci\u003eNovel and Re-emerging Respiratory Viral Diseases\u003c\/i\u003e offers a comprehensive and interdisciplinary account of all aspects of the topic, from basic molecular biology to public health issues, and is therefore essential reading for virologists, infectious disease specialists, public health managers, researchers and epidemiologists, as well as those working in vaccine development, pharmaceutical medicine and drug discovery\u003c\/p\u003e  \u003ci\u003eSymposium on Novel and re-emerging respiratory viral diseases, held at the Institute of Molecular and Cell Biolog y, Singapore, 23–25 April 2007.\u003c\/i\u003e  \u003cp\u003e\u003ci\u003eEditors: Gregory Bock (Organizer) and Jamie Goode.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eThis meeting was based on a proposal made by Yee-Joo Tan and Wanjin Hong.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eRobert G. Webster\u003c\/b\u003e Chair’s introduction.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eLarry J. Anderson\u003c\/b\u003e and \u003cb\u003eSuxiang Tong\u003c\/b\u003e Identification and characterization of novel viruses.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eEdward C. Holmes\u003c\/b\u003e The evolution of viral emergence.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eDerek J. Smith, Jan C. de Jong, Alan S. Lapedes, Terry C. Jones, Colin A. Russell, Theo M. Bestebroer, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus\u003c\/b\u003e and \u003cb\u003eRon A. M. Fouchier\u003c\/b\u003e Antigenic artography of human and swine influenza A (H3N2) viruses.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eGabriele Neumann\u003c\/b\u003e and \u003cb\u003eYoshihiro Kawaoka\u003c\/b\u003e Infl uenza pandemics and control.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJ. J. Skehel, S. Wharton, L. Calder\u003c\/b\u003e and \u003cb\u003eD. Stevens\u003c\/b\u003e On the activation of membrane fusion by influenza haemagglutinin.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eYee Sin Leo\u003c\/b\u003e Singapore SARS experience and preparation for future outbreak.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eYee-Joo Tan\u003c\/b\u003e SARS lessons for a young virology laboratory in Singapore.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIh-Jen Su\u003c\/b\u003e How the SARS experience has helped preparations for future outbreaks: the Taiwan experience, with emphasis on the successful control of institutional outbreak of influenza in 2003\/2004 using a stockpile of antivirals.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eGeneral discussion I.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eYuelong Shu, Yu Lan, Leying Wen, Ye Zhang, Jie Dong, Xinsheng Zhao, Dayan Wang, Lihong Yao, Xiyan Li, Wei Wang, Xiuping Wang, Qi Wang, Shumin Duan, Jingjing Huang, Lei Yang, Hongjie Yu, Yuanji Guo, Weizhong Yang, Xiyan Xu, Nancy J. Cox, Xiaoping Dong, Yu Wang\u003c\/b\u003e and \u003cb\u003eDexin Li\u003c\/b\u003e Genetic and antigenic characterization of avian influenza A (H5N1) viruses isolated from humans in Mainland China.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJ. S. M. Peiris\u003c\/b\u003e and \u003cb\u003eY. Guan\u003c\/b\u003e Emerging infectious diseases and the animal–human interface.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eErich Hoffmann, Hui-Ling Yen, Rachelle Salomon, Neziha Yilmaz\u003c\/b\u003e and \u003cb\u003eRobert G. Webster\u003c\/b\u003e Transmission and pathogenicity of H5N1 influenza viruses.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJohn M. Wood\u003c\/b\u003e Development of vaccine for a future influenza pandemic.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDiscussion.\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eFinal discussion.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIndex of contributors.\u003c\/p\u003e \u003cp\u003eSubject index.\u003c\/p\u003e \"This is a valuable account of how new viral pathogens are discovered and analyzed. It also describes how a highly infectious outbreak can be contained. This information will be invaluable in future outbreaks. This book is highly recommended for individuals involved in diagnosing and containing infectious viral diseases.\" (\u003ci\u003eDoody's\u003c\/i\u003e, January 2009)  \u003cp\u003e\u003cstrong\u003e The Novartis Foundation\u003c\/strong\u003e is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eChairman:\u003c\/strong\u003e Robert G Webster, St. Jude Children's?Research Hospital, Memphis, USA.   The past decade has seen mounting global concern regarding viral outbreaks such as SARS, avian influenza and West Nile virus. In 2004 and 2005, reports of bird-to-human, and possible human-to-human, transmissions of the H5N1 influenza viruses raised fears that these viruses could cause a pandemic on the scale of the Spanish flu pandemic of 1918.   Previous to this, a novel coronavirus had been identified as the aetiological agent of the severe acute respiratory syndrome (SARS), a new respiratory viral disease that emerged at the end of 2002 and caused profound disturbances in over 30 countries worldwide in 2003. It is not known whether the SARS coronavirus will re-emerge, especially since its origins and potential reservoir(s) are unresolved. However, these outbreaks have shown that these viruses can emerge in any part of the world at any time.  \u003c\/p\u003e\u003cp\u003eThis book critically evaluates the latest scientific evidence on novel or re-emerging viral diseases and brings together contributions from world experts on this topic, explaining best practice in their area, and discussing lessons learned and how best to collaborate to prevent and control future outbreaks.\u003c\/p\u003e \u003cp\u003eTopics covered include:\u003c\/p\u003e \u003cul type=\"disc\"\u003e \u003cli\u003ethe latest advances in virology, particularly in the area of epidemiology\u003c\/li\u003e \u003cli\u003ediagnostics\u003c\/li\u003e \u003cli\u003eanimal models for viral infection, and\u003c\/li\u003e \u003cli\u003eantiviral and vaccine development.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003ci\u003eNovel and Re-emerging Respiratory Viral Diseases\u003c\/i\u003e offers a comprehensive and interdisciplinary account of all aspects of the topic, from basic molecular biology to public health issues, and is therefore essential reading for virologists, infectious disease specialists, public health managers, researchers and epidemiologists, as well as those working in vaccine development, pharmaceutical medicine and drug discovery\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47989700133093,"sku":"NP9780470065389","price":211.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470065389.jpg?v=1761785156","url":"https:\/\/k12savings.com\/products\/novel-and-re-emerging-respiratory-viral-diseases-isbn-9780470065389","provider":"K12savings","version":"1.0","type":"link"}